Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. [electronic resource] by
- Lin, X
- Rice, K L
- Buzzai, M
- Hexner, E
- Costa, F F
- Kilpivaara, O
- Mullally, A
- Soares, M B
- Ebert, B L
- Levine, R
- Licht, J D
Producer: 20130404
In:
Leukemia vol. 27
Availability: No items available.
|
|
16.
|
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes. [electronic resource] by
- Murphy, D M
- Bejar, R
- Stevenson, K
- Neuberg, D
- Shi, Y
- Cubrich, C
- Richardson, K
- Eastlake, P
- Garcia-Manero, G
- Kantarjian, H
- Ebert, B L
- Mike Makrigiorgos, G
Producer: 20131210
In:
Leukemia vol. 27
Availability: No items available.
|
|
17.
|
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. [electronic resource] by
- Rice, K L
- Lin, X
- Wolniak, K
- Ebert, B L
- Berkofsky-Fessler, W
- Buzzai, M
- Sun, Y
- Xi, C
- Elkin, P
- Levine, R
- Golub, T
- Gilliland, D G
- Crispino, J D
- Licht, J D
- Zhang, W
Producer: 20121002
In:
Blood cancer journal vol. 1
Availability: No items available.
|